Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Perlin

Showing results (91-100 of 284) with videos related to

Pageof 29
Sort By:
Antimicrobial Agents and Chemotherapy|April 11, 2018
Understanding Echinocandin Resistance in the Emerging Pathogen Candida aurisMilena Kordalewska, Annie Lee, Steven Park, et al.
Mycopathologia|August 15, 2014
Killing rates for caspofungin against Candida albicans after brief and continuous caspofungin exposure in the presence and absence of serumRenátó Kovács, Rudolf Gesztelyi, David S Perlin, et al.
Medical Mycology|June 24, 2016
Blood Aspergillus RNA is a promising alternative biomarker for invasive aspergillosisYanan Zhao, Padmaja Paderu, Radha Railkar, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2002
Prospective, multicenter surveillance study of Candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in New York City (Candida Susceptibility Trends Study, 1998 to 1999)Amar Safdar, Vishnu Chaturvedi, Brian S Koll, et al.
Mbio|August 10, 2021
Multifactorial Role of Mitochondria in Echinocandin Tolerance Revealed by Transcriptome Analysis of Drug-Tolerant CellsRocio Garcia-Rubio, Cristina Jimenez-Ortigosa, Lucius DeGregorio, et al.
Journal of Clinical Microbiology|February 1, 2008
Rapid detection of triazole antifungal resistance in Aspergillus fumigatusGuillermo Garcia-Effron, Amanda Dilger, Laura Alcazar-Fuoli, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2008
Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicansNathan P Wiederhold, Jodi L Grabinski, Guillermo Garcia-Effron, et al.
Plos Pathogens|June 10, 2010
Requirement for ergosterol in V-ATPase function underlies antifungal activity of azole drugsYong-Qiang Zhang, Soledad Gamarra, Guillermo Garcia-Effron, et al.
Antimicrobial Agents and Chemotherapy|October 24, 2012
Evaluation of caspofungin susceptibility testing by the new Vitek 2 AST-YS06 yeast card using a unique collection of FKS wild-type and hot spot mutant isolates, including the five most common candida speciesKaren M Astvad, David S Perlin, Helle K Johansen, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2017
The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Murine Model of Candida glabrata Colonization and Systemic DisseminationKelley R Healey, Yoji Nagasaki, Matthew Zimmerman, et al.
Pageof 29

Showing results (91-100 of 284) with videos related to

Sort By:
Pageof 29
Antimicrobial Agents and Chemotherapy|April 11, 2018
Understanding Echinocandin Resistance in the Emerging Pathogen Candida aurisMilena Kordalewska, Annie Lee, Steven Park, et al.
Mycopathologia|August 15, 2014
Killing rates for caspofungin against Candida albicans after brief and continuous caspofungin exposure in the presence and absence of serumRenátó Kovács, Rudolf Gesztelyi, David S Perlin, et al.
Medical Mycology|June 24, 2016
Blood Aspergillus RNA is a promising alternative biomarker for invasive aspergillosisYanan Zhao, Padmaja Paderu, Radha Railkar, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2002
Prospective, multicenter surveillance study of Candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in New York City (Candida Susceptibility Trends Study, 1998 to 1999)Amar Safdar, Vishnu Chaturvedi, Brian S Koll, et al.
Mbio|August 10, 2021
Multifactorial Role of Mitochondria in Echinocandin Tolerance Revealed by Transcriptome Analysis of Drug-Tolerant CellsRocio Garcia-Rubio, Cristina Jimenez-Ortigosa, Lucius DeGregorio, et al.
Journal of Clinical Microbiology|February 1, 2008
Rapid detection of triazole antifungal resistance in Aspergillus fumigatusGuillermo Garcia-Effron, Amanda Dilger, Laura Alcazar-Fuoli, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2008
Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicansNathan P Wiederhold, Jodi L Grabinski, Guillermo Garcia-Effron, et al.
Plos Pathogens|June 10, 2010
Requirement for ergosterol in V-ATPase function underlies antifungal activity of azole drugsYong-Qiang Zhang, Soledad Gamarra, Guillermo Garcia-Effron, et al.
Antimicrobial Agents and Chemotherapy|October 24, 2012
Evaluation of caspofungin susceptibility testing by the new Vitek 2 AST-YS06 yeast card using a unique collection of FKS wild-type and hot spot mutant isolates, including the five most common candida speciesKaren M Astvad, David S Perlin, Helle K Johansen, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2017
The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Murine Model of Candida glabrata Colonization and Systemic DisseminationKelley R Healey, Yoji Nagasaki, Matthew Zimmerman, et al.
Pageof 29